These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 17013436
1. [Are there any positive effects of TNF-alpha blockers on bone metabolism?]. Seriolo B, Paolino S, Sulli A, Cutolo M. Reumatismo; 2006; 58(3):199-205. PubMed ID: 17013436 [Abstract] [Full Text] [Related]
3. Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study. Durnez A, Paternotte S, Fechtenbaum J, Landewé RB, Dougados M, Roux C, Briot K. J Rheumatol; 2013 Oct; 40(10):1712-8. PubMed ID: 23950191 [Abstract] [Full Text] [Related]
4. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis. Szentpetery A, McKenna MJ, Murray BF, Ng CT, Brady JJ, Morrin M, Radovits B, Veale DJ, Fitzgerald O. J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381 [Abstract] [Full Text] [Related]
5. Bone status in adults with early-onset juvenile idiopathic arthritis following 1-year anti-TNFα therapy and discontinuation of glucocorticoids. Brabnikova Maresova K, Jarosova K, Pavelka K, Stepan JJ. Rheumatol Int; 2013 Aug; 33(8):2001-7. PubMed ID: 23370856 [Abstract] [Full Text] [Related]
7. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, Dijkmans BA, Woolf AD, Kvien TK, Lems WF. Ann Rheum Dis; 2006 Nov; 65(11):1495-9. PubMed ID: 16606653 [Abstract] [Full Text] [Related]
8. [Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients peripheral blood mononuclear cells stimulated with lipopolysaccharide]. Fabris M, Tolusso B, Gremese E, Tomietto P, Ferraccioli G. Reumatismo; 2004 Nov; 56(2):94-103. PubMed ID: 15309217 [Abstract] [Full Text] [Related]
10. Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone. Wisłowska M, Jakubicz D. Rheumatol Int; 2007 May; 27(7):641-7. PubMed ID: 17235556 [Abstract] [Full Text] [Related]
11. The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis. Kang KY, Lee KY, Kwok SK, Ju JH, Park KS, Hong YS, Kim HY, Park SH. Joint Bone Spine; 2011 Mar; 78(2):188-93. PubMed ID: 20621536 [Abstract] [Full Text] [Related]
12. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss. Wijbrandts CA, Klaasen R, Dijkgraaf MG, Gerlag DM, van Eck-Smit BL, Tak PP. Ann Rheum Dis; 2009 Mar; 68(3):373-6. PubMed ID: 18408246 [Abstract] [Full Text] [Related]
13. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T. Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538 [Abstract] [Full Text] [Related]
14. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor. Hjeltnes G, Hollan I, Førre O, Wiik A, Lyberg T, Mikkelsen K, Agewall S. Clin Exp Rheumatol; 2013 Mar; 31(3):415-21. PubMed ID: 23465067 [Abstract] [Full Text] [Related]
17. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study. Lange U, Teichmann J, Müller-Ladner U, Strunk J. Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785 [Abstract] [Full Text] [Related]